These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 10810551)

  • 1. Borderline epithelial tumours of the ovary--a retrospective analysis of 31 cases.
    Kane SV; Bharadwaj R; Tongaonkar HB
    Indian J Cancer; 1999 Mar; 36(1):18-31. PubMed ID: 10810551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors.
    Prayson RA; Hart WR; Petras RE
    Am J Surg Pathol; 1994 Jun; 18(6):591-603. PubMed ID: 8179074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of peritoneal extensions for the diagnosis and management of serous ovarian borderline tumors].
    Andrei S; Stolnicu S; Rădulescu D; Mocan S; Puşcaşu L
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):679-86. PubMed ID: 17571566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathology of and controversial aspects of ovarian borderline tumours.
    McCluggage WG
    Curr Opin Oncol; 2010 Sep; 22(5):462-72. PubMed ID: 20531187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian serous borderline tumors with invasive peritoneal implants.
    Gershenson DM; Silva EG; Levy L; Burke TW; Wolf JK; Tornos C
    Cancer; 1998 Mar; 82(6):1096-103. PubMed ID: 9506355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucinous tumors of the ovary: a review.
    Hart WR
    Int J Gynecol Pathol; 2005 Jan; 24(1):4-25. PubMed ID: 15626914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial ovarian tumors of borderline malignancy: long-term follow-up.
    Casey AC; Bell DA; Lage JM; Fuller AF; Nikrui N; Rice LW
    Gynecol Oncol; 1993 Sep; 50(3):316-22. PubMed ID: 8406194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial neoplasms of the ovary. An update on current concepts.
    Gordon MD; Ireland K
    Clin Lab Med; 1995 Sep; 15(3):575-93. PubMed ID: 8542724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An analysis of pathologic features and prognostic factors of 10 cases with pseudomyxoma peritonei].
    Zhou X; Du X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):543-6. PubMed ID: 8556915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'.
    Lee KR; Scully RE
    Am J Surg Pathol; 2000 Nov; 24(11):1447-64. PubMed ID: 11075847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors?
    Cho YH; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
    Gynecol Oncol; 2006 Dec; 103(3):878-82. PubMed ID: 16859736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphology of borderline mucinous ovarian tumors].
    Karseladze AI
    Arkh Patol; 1989; 51(5):40-6. PubMed ID: 2549923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface epithelial tumours of the ovary.
    Maheshwari V; Tyagi SP; Saxena K; Tyagi N; Sharma R; Aziz M; Hameed F
    Indian J Pathol Microbiol; 1994 Jan; 37(1):75-85. PubMed ID: 8088904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
    Evans MF; McDicken IW; Herrington CS
    J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low grade malignant ovarian carcinomas. A retrospective study of 132 cases].
    Randrianjafisamindrakotroka NS; Hedelin G; Philippe E; Schaffer P
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(7):761-7. PubMed ID: 1469230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ovarian tumors of low malignant potential (borderline ovarian tumors)].
    Luchian AM; Pricop M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):438-45. PubMed ID: 21870737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence and location of epithelial implants and implants with epithelial proliferation may predict a higher risk of recurrence in serous borderline ovarian tumors: a clinicopathologic study of 188 cases.
    Quddus MR; Sung CJ; Zhang C; Moore RG; Ou JJ; Steinhoff MM; Lawrence WD
    Hum Pathol; 2012 May; 43(5):747-52. PubMed ID: 22047646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.